Robocore Raises $30M from Foxconn to Scale Global Service Robots

Foxconn Technology Group, a global electronics contract manufacturer, has made a US$30 million investment in Hong Kong’s Robocore Technology. The funding was channeled through Foxconn’s subsidiary, Q-Run Holdings Limited, and is directed toward Robocore’s fully owned unit, RoboTemi Global Ltd. This investment is part of Robocore’s recently concluded Series D funding round, marking Foxconn’s entry into the smart robotics sector.

The investment starts with a US$10 million tranche, giving Foxconn a 6.6% stake, followed by two further tranches of US$10 million each over the next two years. Based at Hong Kong Science Park, Robocore intends to use the capital to grow its medical and eldercare robotics operations, while also supporting Foxconn’s wider AI and smart manufacturing initiatives.

Robocore founder and CEO Roy Lim Long-hei described the Foxconn investment as more than just financial support, calling it “an affirmation of our company’s future prospects.” He noted that Foxconn Technology’s extensive manufacturing capabilities and supply chain network would help Robocore accelerate growth and enter new markets, while also paving the way for a potential U.S. initial public offering within the next five years.

With the funding, Foxconn chalks out a broader strategy to diversify beyond smartphones into AI servers, cloud, and networking products. By backing Robocore, the Taiwanese electronics giant, listed as Hon Hai Precision Industry on the Taiwan Stock Exchange, is making a significant move into the smart robotics sector.

Robocore creates, engineers, and produces programmable service robots for sectors such as healthcare, education, consumer services, and intelligent facility management. Its Israel-based arm, RoboTemi Global, develops the AI-powered temi robot, a smart home assistant that serves as the centerpiece of Robocore’s global product lineup.

The Series D funding kicks off with an initial US$10 million investment, giving Foxconn a 6.6% stake in RoboTemi Global. Two additional tranches of US$10 million each are scheduled for the first and second anniversaries of this initial funding. Robocore noted that the valuation for these future investments will be set through mutual agreement or independent assessment. Earlier backers of the startup include Singapore-based Fenghe Group and China’s Joy Capital.

Proceeds from the funding will primarily support Robocore’s telemedicine operations across the U.S., Europe, and Japan, while also financing the launch of new consumer products in mainland China and the expansion of global sales and marketing efforts. Lim highlighted that production is currently split between Taiwan and Dongguan, with Taiwan ramping up to meet U.S. healthcare demand, especially given favorable tariff conditions.

Robocore expects the investment to drive a three-fold increase in revenue over the next three years, targeting a five-fold growth by 2028. Its products are currently deployed at nearly 20,000 client sites globally, including 5,000 in the U.S., spanning hospitals, elderly care facilities, retail chains, and private households.

Image credits: Robocore